X
ACHEMA MIDDLE EAST
Pharma Advancement
DDF Summit
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Sodium Oxybate Oral Solution

    Amneal Secures FDA Approval for Sodium Oxybate Oral Solution

    Bladder Cancer Treatment

    US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

    Lilly TuneLab

    Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

    Sensor Technology

    Enhancing Clinical Research with Advanced Sensor Technology

    Recombinant VWF

    FDA Approves Recombinant VWF Treatment in Pediatric Patients

    Novartis and Argo

    Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

    Novartis and Arrowhead

    Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug

    Eisais Leqembi IQLIK

    FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

    FDA Approves Sanofis Wayrilz

    FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Sodium Oxybate Oral Solution

    Amneal Secures FDA Approval for Sodium Oxybate Oral Solution

    Bladder Cancer Treatment

    US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

    Lilly TuneLab

    Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

    Sensor Technology

    Enhancing Clinical Research with Advanced Sensor Technology

    Recombinant VWF

    FDA Approves Recombinant VWF Treatment in Pediatric Patients

    Novartis and Argo

    Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

    Novartis and Arrowhead

    Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug

    Eisais Leqembi IQLIK

    FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

    FDA Approves Sanofis Wayrilz

    FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Thermo Fisher Scientific Introduces Next Generation of Complementary Technologies for Forensic DNA Analysis

Yuvraj_pawp by Yuvraj_pawp
18th July 2017
in Asia, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes, now have access to a new next-generation sequencing (NGS) STR panel from Thermo Fisher Scientific. The combination of Applied Biosystems Precision ID GlobalFiler NGS STR Panel v2 and Converge Software 2.0 is designed to effectively retrieve more information from these mixed, degraded or limited DNA samples.

 

Forensic scientists have traditionally used capillary electrophoresis (CE) to analyze STR markers for genetic profile comparisons with known individuals from the FBI’s Combined DNA Index System (CODIS) database and other databases worldwide. However, complicating factors, such as DNA degradation, mixtures and/or insufficient starting material, prevent an estimated 30-40 percent of samples from offering conclusive results.


The new Precision ID GlobalFiler NGS STR Panel v2 is designed to work seamlessly with the Ion Chef System for automated library and template preparation and sequencing on the Ion S5 and Ion S5 XL Systems, which offer as little as two hour sequencing run times and 15 minutes of hands-on time. The panel targets CODIS expanded core loci, with additional multi-allelic STR markers, including Penta D and Penta E, as well as sex determination markers. This expanded marker set assists in mixture resolution for identifying multiple contributors in complex casework samples.


The new Converge NGS Analysis module is required to generate profiles from the Precision ID GlobalFiler NGS STR Panel v2. The HID STR genotyping functionality provides information on length-based STR allele call, sequence-based repeat motif, known SNPs in flanking regions, and isometric heterozygote (alleles of the same fragment length, but containing different repeat sequence) information. These additional sequence-based characteristics will deliver a wider allele range with an increased power of discrimination for individual identification. With an interface which is similar to Applied Biosystems GeneMapper ID-X software, forensic analysts can easily evaluate sequencing data using familiar Process Quality Values and flags, such as allele number (AN), off-ladder allele (OL), peak height ratio (PHR), below stochastic threshold (BST) and Control Concordance (CC).


“NGS now has the ability to transform forensic genetics by enabling the recovery of highly discriminating allelic profiles from challenging mixed or degraded samples,” said Claus Børsting, Ph.D., senior advisor at the Section of Forensic Genetics, Department of Forensic Medicine, University of Copenhagen, Denmark. “Our tests show full concordance with CE based methods, high sensitivity, and new possibilities for mixture interpretation. Under our ISO 17025 laboratory accreditation, we have used NGS in relationship case work since 2015. Currently, we are validating an ancestry panel to bring NGS on-line in crime case work.”


“Our customers need more access to genetic identification profiles from complex DNA samples, prompting the continued development of the Precision ID NGS System, additional panels and a more comprehensive data analysis pipeline.” said Rosy Lee, vice president and general manager of human identification at Thermo Fisher Scientific.


Additional information on the Precision ID NGS System with Converge software can be found here.
The Precision ID NGS System is for research, forensic or paternity use only; Not for use in diagnostic procedures.


About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com

 

Media Contact Information:

Mauricio Minotta, Thermo Fisher Scientific
+1 760 929 2456
mauricio.minotta@thermofisher.com

Tags: Middle East & South Asia
Previous Post

DelMar Pharmaceuticals Receives IRB Approval for Pivotal Phase 3 Clinical Trial of VAL-083

Next Post

PersonalMed Partners with Bergen’s Elevate Provider Network to Assist Compounding Pharmacies

Related Posts

Sodium Oxybate Oral Solution
Drug Development

Amneal Secures FDA Approval for Sodium Oxybate Oral Solution

17th September 2025
misleading drug advertising
Facilities & Operation

US FDA Tightens Oversight on Misleading Drug Advertising

16th September 2025
Bladder Cancer Treatment
Drug Development

US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

13th September 2025
Lilly TuneLab
Drug Development

Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

12th September 2025
Recombinant VWF
Drug Development

FDA Approves Recombinant VWF Treatment in Pediatric Patients

9th September 2025
Novartis and Argo
Drug Development

Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

8th September 2025
Next Post

PersonalMed Partners with Bergen’s Elevate Provider Network to Assist Compounding Pharmacies

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In